EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Acute vulvar ulcer as a possible adverse event of gene‐based COVID ‐19 vaccines: A review of 14 cases

Hiromi Kanetani, Tomoka Obuchi, Hiroshi Ishikawa iD, Makio Shozu iD

Journal of Obstetrics and Gynaecology Research · 2023-07 · 49 (7) · 1846-1853

DOI: 10.1111/jog.15647 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Obstetrics and Gynaecology Research, online erschienen am 17.04.2023. Verfasst von Hiromi Kanetani und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Chiba Aoba Municipal Hospital. Hauptthemen laut MEDLINE: COVID-19, COVID-19 Vaccines, Vulvar Diseases. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 30 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

To evaluate whether an acute vulvar ulcer that developed after the COVID‐19 vaccine administration is an adverse effect of the vaccine.

Methods

This is a descriptive study of two cases that we observed in addition to cases that have been reported in the literature. We searched for case reports in the PubMed. The consistency of clinical manifestations among cases and the association between ulceration and vaccination were assessed.

Results

Fourteen female patients were identified, including 12 patients from 8 literatures published in 2021 and 2022 and 2 patients from our cases. Of the 14 patients, 11 had received the BNT162b2 vaccine, 2 had received the ChAdOx1 nCoV‐19 vaccine, and one had received the mRNA‐1273 vaccine. The patient's ages were 16.9 ± 5.0 (mean ± SD) years. Postvaccination, the disease progressed in the following sequence (time interval from vaccination): fever and other systemic inflammatory reactions (0.9 ± 0.4 days), development of vulvar ulcers (2.4 ± 1.2 days), and resolution of the ulcer (16.9 ± 7.4 days). The ulcers eventually healed in all cases, except one where the prognosis was not noted. For two‐dose vaccine recipients, more patients developed the ulcer after the full vaccination (the second or third doses) compared with after the first dose: n = 10 and n = 2, respectively.

Conclusion

The acute vulvar ulcer was closely associated with COVID‐19 vaccination in terms of temporality and vaccine doses, supporting the notion that a vulvar ulcer is an adverse event of the COVID‐19 vaccines.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19COVID-19 VaccinesVulvar DiseasesFemaleHumans2019-nCoV Vaccine mRNA-1273BNT162 VaccineChAdOx1 nCoV-19UlcerVaccination

Stichwörter der Autor:innen

COVID-19 vaccineadolescentadverse eventmRNA vaccinesvulvar ulcer

Substanzen

2019-nCoV Vaccine mRNA-1273BNT162 VaccineChAdOx1 nCoV-19COVID-19 Vaccines

Autor:innen und Institutionen

  • Department of Obstetrics and Gynecology, Chiba Aoba Municipal Hospital.
  • Reproductive Medicine, Chiba University Hospital, Chiba University, Chiba, Japan.
  • Evolution and Reproductive Medicine, Medical Mycology Research Center, Chiba University, Chiba, Japan.

ORCID-Profile: Hiroshi Ishikawa, Makio Shozu

Zitieren

APA

Kanetani, H., Obuchi, T., Ishikawa, H., & Shozu, M. (2023). Acute vulvar ulcer as a possible adverse event of gene‐based COVID ‐19 vaccines: A review of 14 cases. Journal of Obstetrics and Gynaecology Research, 49(7), 1846-1853. https://doi.org/10.1111/jog.15647

Vancouver

Kanetani H, Obuchi T, Ishikawa H, Shozu M. Acute vulvar ulcer as a possible adverse event of gene‐based COVID ‐19 vaccines: A review of 14 cases. Journal of Obstetrics and Gynaecology Research. 2023;49(7):1846-1853. doi:10.1111/jog.15647

BibTeX
@article{Kanetani2023,
  author = {Kanetani, Hiromi and Obuchi, Tomoka and Ishikawa, Hiroshi and Shozu, Makio},
  title = {Acute vulvar ulcer as a possible adverse event of gene‐based COVID ‐19 vaccines: A review of 14 cases},
  journal = {Journal of Obstetrics and Gynaecology Research},
  year = {2023},
  volume = {49},
  number = {7},
  pages = {1846--1853},
  doi = {10.1111/jog.15647}
}
Kostenlos starten →